z-logo
open-access-imgOpen Access
No current evidence supporting risk of using Ibuprofen in patients with COVID‐19
Author(s) -
MartinsFilho Paulo Ricardo,
NascimentoJúnior Edmundo Marques,
Santos Victor Santana
Publication year - 2020
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/ijcp.13576
Subject(s) - medicine , ibuprofen , angiotensin ii , hypoxia (environmental) , hypoxic pulmonary vasoconstriction , stimulation , lung , pneumonia , receptor , immunology , pharmacology , chemistry , organic chemistry , oxygen

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom